Clinics in Dermatology
Volume 27, Issue 6 , Pages 588-593, November 2009

What sentinel node biopsy in patients with melanoma (or patients whose doctors worry that they could have melanoma) might and might not do

Departments of Pathology and Dermatology, University of California at San Francisco School of Medicine, 1701 Divisadero Street, Suite 350, San Francisco, CA 94115, USA

Abstract 

The sentinel lymph node biopsy has taught us important lessons about the behavior of melanoma and, perhaps, of melanocytic nevi. It is of proven prognostic importance in patients whose diagnosis of melanoma is clear-cut. Sentinel lymph node biopsy is an imperfect prognostic tool, however, and although the morbidity of the procedure is low, completion lymphadenectomy has a high morbidity rate and unproven benefit. In the setting of a borderline lesion, small nodal deposits must be interpreted with caution.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0738-081X(08)00193-4

doi:10.1016/j.clindermatol.2008.09.016

Clinics in Dermatology
Volume 27, Issue 6 , Pages 588-593, November 2009